Phase 1/2 study of concurrent chemoradiotherapy with weekly irinotecan hydrochloride for advanced/recurrence uterine cancer: A multi-institutional study of Kansai Clinical Oncology Group

OBJECTIVE: Concurrent chemoradiotherapy using cisplatin was thought to be standard treatment for squamous cell carcinoma of cervix, but it had not been effective for adenocarcinoma. Concurrent chemoradiotherapy using irinotecan hydrochloride (CPT-11) had been effective for colorectal cancer, thus, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Takeuchi, Satoshi, Kuroboshi, Haruo, Mori, Taisuke, Ito, Kimihiko, Kondo, Eiji, Tabata, Tsutomu, Itani, Yoshio, Kawaguchi, Ryuji, Takeuchi, Kyosuke, Soejima, Toshinori, Sasaki, Ryohei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7219098/
https://www.ncbi.nlm.nih.gov/pubmed/32410799
http://dx.doi.org/10.21147/j.issn.1000-9604.2020.02.09

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7219098/
https://www.ncbi.nlm.nih.gov/pubmed/32410799
http://dx.doi.org/10.21147/j.issn.1000-9604.2020.02.09

Ejemplares similares